Pradaxa Lawsuits Claim Drug is Dangerous, Defective

Last Updated on June 26, 2017

Investigation Complete

Comments |

At A Glance

This Alert Affects
Patients who experienced internal bleeding while taking Pradaxa.
Internal bleeding in the kidneys, gastrointestinal tract, and brain.
Boehringer Ingelheim Pharmaceuticals
What is Pradaxa?
Pradaxa (dabigatran etexilate) is a blood thinner used to reduce the risk of stroke in patients with atrial fibrillation.
FDA Warning
On December 7, 2011, the FDA issued a safety announcement regarding Pradaxa, warning of "serious bleeding events" and urging patients to consult their healthcare professionals if bleeding or unusual bruising occurred.
Type of Lawsuit
Mass Tort